Gut drug gets brain test: can it sharpen minds in schizophrenia?
NCT ID NCT06474286
Summary
This small, early-stage study is testing whether a drug normally used for constipation (prucalopride) can help improve thinking, memory, and problem-solving skills in people with schizophrenia. Thirty-four stable patients will take the drug for four weeks alongside their regular antipsychotic medication. Researchers will measure changes in their cognitive test scores and overall symptoms to see if the drug shows any promise.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
K S Hegde Medical Academy,
Mangalore, Karnataka, 575018, India
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.